Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Proacta raises $35mm through Series B round

Executive Summary

Proacta (therapeutics for solid tumors) raised $35mm in its Series B round that was led by new investor Clarus Ventures. Other new buyer Delphi Ventures joined existing backers Alta Partners, GBS Venture Partners, affiliates of the New Zealand Venture Investment Fund (No. 8 Ventures and Endeavour iCap), Genentech, and Roche. An executive from both of the new buyer groups will join Proacta's board.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies